|
Mutation Information
|
Mutation Site
|
T215Y |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Relevant Drug
|
NRTIs |
|
Country
|
Europe;Sub‐Saharan Africa;South America;Middle East;South‐east Asia |
Literature Information
|
PubMed PMID
|
32964671
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2021 |
|
Journal
|
HIV medicine |
|
Title
|
Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors. |
|
Author
|
Borghetti A,Ciccullo A,Lombardi F,Baldin G,Belmonti S,Prosperi M,Incardona F,Heger E,Borghi V,Sönnerborg A,Zazzi M,De Luca A,Di Giambenedetto S |
|
Evidence
|
Among TDRMs with a potential impact on the NRTI employed, M184V/I was the most frequent (19 cases, 1.7%), followed by M41L (17 cases, 1.6%), T215F/Y (five cases, 0.5%), L74V (four cases, 0.4%), L210W (four cases, 0.4%), Y115F (three cases, 0.3%), K70R (three cases, 0.3%) and K65R (two cases, 0.2%).
|
|
|
HIV Mutation Detail Information